Clinical Trial

Monitoring Blood Pressure at Home and Pharmacy Telehealth

Study acronym: REMAP-BP
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
The overall goal of this project is to determine if measuring blood pressure at home and staying in contact with a team of pharmacists and physicians to manage participants' blood pressure is useful. The study will enroll 400 participants who are seen at the University of Alabama at Birmingham Emergency Department - Transitional Care Clinic and Tampa General Hospital -Transitional Care Clinic. Half of the participants (200 patients) will be asked to measure blood pressure at home, and half of the participants (200 patients) will continue to receive usual care. Participants who measure blood pressure at home will also meet with a pharmacist weekly over the phone to discuss blood pressure readings and have blood pressure medications prescribed if needed. This program will last 6 months.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-05-28.
Trial Details
NCT Number NCT07623291
Lead Sponsor University of Alabama at Birmingham
Collaborators: National Heart, Lung, and Blood Institute (NHLBI)
Conditions Hypertension, Blood Pressure
Enrollment 420 participants
Start Date 2027-04-01
Primary Completion 2031-01 (estimated)
Study Completion 2031-01 (estimated)
Updated on ClinicalTrials.gov 2026-06-15